Sign in
av/acurx-pharmaceuticals--big.svg

COM:ACURXPHARMA

Acurx Pharmaceuticals, Inc.

  • Stock

Last Close

2.21

30/08 20:00

Market Cap

34.97M

Beta: -

Volume Today

31.32K

Avg: -

OverviewAnalysisFinancialsFilingspeopleAPIChartData
Income StatementBalance SheetCash FlowKey MetricsRatios
Quarterly
Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
average payables
1.03M
-
1.03M
0%
average receivables
64.58K
-
book value per share
0.11
-
0.28
159.09%
1.45
413.47%
0.68
53.48%
0.37
45.54%
capex per share
capex to depreciation
capex to operating cash flow
capex to revenue
cash per share
0.33
-
0.33
0.54%
1.52
356.16%
0.84
44.51%
0.59
29.98%
days of inventory on hand
days payables outstanding
days sales outstanding
debt to assets
0.02
-
debt to equity
0.02
-
dividend yield
earnings yield
-0.10
-
-0.06
39.02%
-0.34
462.61%
-0.28
18.30%
-0.30
6.94%
enterprise value
56.71M
-
72.17M
27.27%
23.93M
66.85%
33.94M
41.83%
41.06M
20.98%
enterprise value over ebitda
-9.56
-
-15.69
64.10%
-1.86
88.16%
-2.81
51.07%
-2.82
0.36%
ev to operating cash flow
-14.23
-
-21.53
51.33%
-4.77
77.84%
-4.50
5.72%
-4.19
6.90%
ev to sales
free cash flow per share
-0.53
-
-0.35
33.88%
-0.59
67.21%
-0.70
18.72%
-0.77
10.92%
free cash flow yield
-0.07
-
-0.04
33.88%
-0.14
205.29%
-0.18
28.90%
-0.20
15.27%
graham net net
0.10
-
0.28
170.29%
1.42
410.44%
0.65
54.08%
0.36
45.17%
graham number
1.39
-
1.75
25.70%
6.97
297.77%
4.12
40.84%
3.09
25.14%
income quality
0.67
-
0.73
8.44%
0.39
46.02%
0.62
58.58%
0.67
7.79%
intangibles to total assets
0
-
0
0
0
0
interest coverage
9.88K
-
interest debt per share
0.01
-
-0.00
-
inventory turnover
invested capital
0.02
-
market cap
59.19M
-
75.28M
27.18%
36.89M
51.00%
43.05M
16.71%
48.53M
12.74%
net current asset value
819.85K
-
2.70M
229.52%
12.41M
359.37%
7.32M
41.06%
4.67M
36.20%
net debt to ebitda
0.42
-
0.68
61.42%
1.01
48.86%
0.75
25.11%
0.51
31.95%
net income per share
-0.79
-
-0.48
39.02%
-1.49
208.14%
-1.12
24.75%
-1.15
2.91%
operating cash flow per share
-0.53
-
-0.35
33.88%
-0.59
67.21%
-0.70
18.72%
-0.77
10.92%
payables turnover
receivables turnover
research and ddevelopement to revenue
return on tangible assets
-2.34
-
-1.43
39.10%
-0.96
32.94%
-1.29
34.78%
-1.89
46.64%
revenue per share
roe
-7.23
-
-1.70
76.46%
-1.02
39.99%
-1.65
61.77%
-3.12
88.98%
roic
-7.23
-
-1.66
77.03%
-1.03
37.87%
-1.65
60.11%
-3.12
88.96%
sales general and administrative to revenue
shareholders equity per share
0.11
-
0.28
159.09%
1.45
413.47%
0.68
53.48%
0.37
45.54%
stock based compensation to revenue
tangible asset value
819.85K
-
2.70M
229.52%
12.41M
359.37%
7.32M
41.06%
4.67M
36.20%
tangible book value per share
0.11
-
0.28
159.09%
1.45
413.47%
0.68
53.48%
0.37
45.54%
working capital
819.85K
-
2.75M
235.60%
12.41M
351.04%
7.32M
41.06%
4.67M
36.20%

All numbers in (except ratios and percentages)